Myconostica Raises $10.8 Million

Myconostica Ltd., a Manchester, UK-based developer of medical tests for life-threatening fungal infections, has raised $10.8 million in third-round funding. Backers include Amphion Innovations, Nexus Medical Partners, Innoven Partenaires, Medicis Ventures and UMIP Premier Fund.

 

PRESS RELEASE

 

Myconostica Ltd, a Manchester UK-based medical diagnostic company which specialises in rapid and highly specific tests for life-threatening fungal infections, today announces that it has completed the third close of a $10.8 million (